Background COVID19 patients may suffer from multiple cardiovascular complications.
Recently, N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) was a …

Objectives This systematic review and meta-analysis aimed to assess the association
between N-terminal pro-brain natriuretic peptide (NT-proBNP) and mortality in patients with …

Introduction: The objective of the present research was to evaluate the possible association
between the N-terminal pro-brain type natriuretic peptide (NT-proBNP) levels and in-hospital …

Background Currently, there is limited research on the prognostic value of NT‐proBNP (N‐
terminal pro‐B‐type natriuretic peptide) as a biomarker in COVID‐19. We proposed the a …

Up to 15% of coronavirus disease 2019 (COVID-19) patients experience severe clinical
presentation, resulting in acute respiratory distress (ARDS) and finally death. N-terminal …

Background The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public …

Increased concentrations of B-type natriuretic peptide (BNP), N-terminal pro-B-type
natriuretic peptide (NT-proBNP) and high-sensitivity troponin I (HsTnI) in COVID-19 patients …

Aims We examined the value of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) in
patients admitted for coronavirus disease 2019 (COVID‐19) without prior history of heart …

Natriuretic peptides are biomarkers of myocardial stress and are frequently elevated among
patients with severe respiratory illnesses, typically in the absence of elevated cardiac-filling …

Aims Extensive research regarding the association of troponin and prognosis in coronavirus
disease 2019 (COVID‐19) has been performed. However, data regarding natriuretic …